AI diagnostics company IDx has signed an exclusivity agreement with ophthalmic device maker Topcon to scale AI-based diagnostic solutions in the US. IDx2300 Oakdale BlvdCoralville, IA 52241Phone: The deal is a significant step forward for both companies as it will allow them to offer their products and services directly to consumers through a single platform. IDx’s AI system, IDx-DR, was approved by the US Food and Drug Administration earlier this year after a clinical trial. Operators with minimal training produced a result 96% of the time, capturing images using the Topcon NW400, which the IDx-DR system needed to make a disease assessment.
AI diagnostics company IDx has signed an exclusivity agreement with ophthalmic device maker Topcon to scale AI-based diagnostic solutions in the US. The deal is a significant step forward for both companies as it will allow them to offer their products and services directly to consumers through a single platform. IDx’s AI system, IDx-DR, was approved by the US Food and Drug Administration earlier this year after a clinical trial. Operators with minimal training produced a result 96% of the time, capturing images using the Topcon NW400, which the IDx-DR system needed to make a disease assessment.